At our core, we are company creators. Our dedicated team of Entrepreneur Partners provide deep domain expertise in research and development, intellectual property, clinical strategy and commercialization – elements that we believe are crucial for successful company building.

MPM BioImpact combines the 30+ year track record of the MPM CAPITAL^® services and offerings in biotech venture capital with BioImpact’s dedication to impact and 10+ years of experience in public investing. Together, we manage over $3 billion AUM across early-stage venture funds, private/public impact funds and a public equities fund.

The BIOIMPACT FUND™ investment approach pioneered by MPM BioImpact features private and public equity funds that invest in companies which aim to transform the lives and outcomes of patients suffering from disease. We are proud to be committed to the Global Standards for managing these impact investments.